Literature DB >> 19348047

Kallikreins and lupus nephritis.

Claudio Ponticelli1, Pier Luigi Meroni.   

Abstract

The kidney kallikrein-kinin system plays important roles in inflammation, coagulation, angiogenesis, and regulation of vessel tone and permeability. In this issue of the JCI, Liu et al. provide data that suggest a protective role for kallikrein in animal models of anti-glomerular basement membrane(GBM) antibody-induced nephritis, an experimental model of Goodpasture disease (see the related article beginning on page 911). Furthermore, human systemic lupus erythematosus and lupus nephritis were shown to be associated with kallikrein 1 (KLK1) and the KLK3 promoter. The authors suggest that kallikrein genes are involved in the development of SLE and lupus nephritis and may exert a renoprotective role. It is possible, however, that the kallikrein-kinin system may play dual roles: protecting the kidney against ischemia and interstitial fibrosis while also mediating vasodilation, inflammation, and activation of the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348047      PMCID: PMC2662572          DOI: 10.1172/jci38786

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

Review 1.  Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus.

Authors:  Casandra C van Bavel; Kristin A Fenton; Ole P Rekvig; Johan van der Vlag; Jo H Berden
Journal:  Arthritis Rheum       Date:  2008-07

2.  Association of the tissue kallikrein gene promoter with ESRD and hypertension.

Authors:  Hongrun Yu; Qing Song; Barry I Freedman; Julie Chao; Lee Chao; Stephen S Rich; Donald W Bowden
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

3.  Kallikrein and kinin receptor expression in inflammation and cancer.

Authors:  K Bhoola; R Ramsaroop; J Plendl; B Cassim; Z Dlamini; S Naicker
Journal:  Biol Chem       Date:  2001-01       Impact factor: 3.915

4.  Kinin system in lupus nephritis.

Authors:  R Dellalibera-Joviliano; M L Reis; E A Donadi
Journal:  Int Immunopharmacol       Date:  2001-09       Impact factor: 4.932

Review 5.  The role of innate immunity in autoimmune tissue injury.

Authors:  Ramanjaneyulu Allam; Hans-Joachim Anders
Journal:  Curr Opin Rheumatol       Date:  2008-09       Impact factor: 5.006

Review 6.  Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.

Authors:  Anne Pizard; Christine Richer; Nadine Bouby; Nicolas Picard; Pierre Meneton; Michel Azizi; François Alhenc-Gelas
Journal:  Biol Chem       Date:  2008-06       Impact factor: 3.915

7.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

8.  Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.

Authors:  Svetlana N Zykova; Natalya Seredkina; Jørgen Benjaminsen; Ole Petter Rekvig
Journal:  Arthritis Rheum       Date:  2008-03

9.  Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families.

Authors:  A Parsa; E Peden; R F Lum; V A Seligman; J L Olson; H Li; M F Seldin; L A Criswell
Journal:  Genes Immun       Date:  2002-10       Impact factor: 2.676

10.  Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.

Authors:  Kui Liu; Quan-Zhen Li; Angelica M Delgado-Vega; Anna-Karin Abelson; Elena Sánchez; Jennifer A Kelly; Li Li; Yang Liu; Jinchun Zhou; Mei Yan; Qiu Ye; Shenxi Liu; Chun Xie; Xin J Zhou; Sharon A Chung; Bernardo Pons-Estel; Torsten Witte; Enrique de Ramón; Sang-Cheol Bae; Nadia Barizzone; Gian Domenico Sebastiani; Joan T Merrill; Peter K Gregersen; Gary G Gilkeson; Robert P Kimberly; Timothy J Vyse; Il Kim; Sandra D'Alfonso; Javier Martin; John B Harley; Lindsey A Criswell; Edward K Wakeland; Marta E Alarcón-Riquelme; Chandra Mohan
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

View more
  7 in total

Review 1.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

2.  From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.

Authors:  Celine C Berthier; Matthias Kretzler; Anne Davidson
Journal:  J Data Mining Genomics Proteomics       Date:  2012-03-27

Review 3.  Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes.

Authors:  Ana Carolina B Stefanini; Bianca Rodrigues da Cunha; Tiago Henrique; Eloiza H Tajara
Journal:  Dis Markers       Date:  2015-12-09       Impact factor: 3.434

4.  The Combination of Human Urinary Kallidinogenase and Mild Hypothermia Protects Adult Rats Against Hypoxic-Ischemic Encephalopathy-Induced Injury by Promoting Angiogenesis and Regeneration.

Authors:  Xiaoya Gao; Haiting Xie; Shuzhen Zhu; Bin Yu; Ying Xian; Qian Ouyang; Yabin Ji; Xiaohua Yang; Chunyan Wen; Penghua Wang; Yufeng Tong; Qing Wang
Journal:  Front Aging Neurosci       Date:  2018-07-11       Impact factor: 5.750

5.  Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis.

Authors:  Ling Qin; Yong Du; Huihua Ding; Anam Haque; John Hicks; Claudia Pedroza; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2019-01-08       Impact factor: 5.156

6.  Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.

Authors:  Jennie Bäck; Christian Lood; Anders A Bengtsson; Kristina Nilsson Ekdahl; Bo Nilsson
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

7.  Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.

Authors:  Alecia Seliga; Michael Hweemoon Lee; Nicole C Fernandes; Viviana Zuluaga-Ramirez; Marta Didukh; Yuri Persidsky; Raghava Potula; Stefania Gallucci; Uma Sriram
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.